JCL Roundtable: Prediabetes

Kevin C Maki1, Carol F Kirkpatrick2, Jaime Almandoz3

  • 1Midwest Biomedical Research, Addison, IL, USA (Drs Maki, Kirkpatrick); Department of Applied Health Science, Indiana University School of Public Health-Bloomington, Bloomington, IN, USA (Dr Maki).

PubMed

Insights

Prediabetes impacts over a third of US adults, increasing risks for type 2 diabetes and other serious conditions. Addressing excess adiposity through lifestyle changes and medication is crucial for management and prevention.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Cardiovascular Health

Background:

  • Prediabetes affects over 1 in 3 US adults, significantly raising risks for type 2 diabetes, cardiovascular disease, chronic kidney disease, and dementia.
  • Excess adiposity is the primary risk factor for prediabetes, exacerbating cardiometabolic issues like dyslipidemia and insulin resistance.

Purpose of the Study:

  • To discuss lifestyle and pharmacologic interventions for managing prediabetes.
  • To explore strategies for preventing associated health risks in prediabetic individuals.
  • To emphasize the role of addressing excess adiposity in prediabetes management.

Main Methods:

  • A roundtable discussion format featuring experts in the field.
  • Exploration of various intervention strategies including lifestyle modifications, pharmacotherapy, and metabolic surgery.
  • Focus on patient-centered care and shared decision-making.

Main Results:

  • Interventions targeting excess adiposity are vital for prediabetes management.
  • A combination of lifestyle, pharmacologic, and surgical approaches can be effective.
  • Shared decision-making is key for patient adherence and treatment success.

Conclusions:

  • Effective management of prediabetes requires addressing excess adiposity through comprehensive strategies.
  • Patient involvement in treatment planning enhances the likelihood of successful outcomes.
  • Timely interventions can mitigate the severe health risks associated with prediabetes.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
494
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
837
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
52